+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID07132333

Prospective Study of Molecular Inflammation Board Care for Adults with Chronic Inflammatory Disorders at University Hospitals in Freiburg, Heidelberg, Tbingen, and Ulm

Led by University Hospital Tuebingen · Updated on 2025-08-20

3000

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

This observational study focuses on patients with chronic inflammatory disorders including psoriasis, psoriatic arthritis, inflammatory bowel disease Crohns disease and ulcerative colitis, and spondylarthropathies. The study is conducted at the Molecular Inflammation Board within the Centers for Personalized Medicine at several university hospitals. The main goals are to document patients referred to the board, track clinical outcomes, and evaluate treatment responses such as immune monitoring and imaging results. The study involves monitoring patients receiving biologic agent treatments as part of their routine clinical care. It tracks patient adherence to the recommended therapies and compliance with treatment suggestions from the Molecular Inflammation Board. This prospective documentation includes recording patient-reported outcomes and clinical response parameters over time. Participants will be followed for an average of one year to observe therapy persistence and treatment effectiveness. Researchers will collect data on clinical outcomes, patient experiences, imaging, and immune response assessments. The study aims to understand treatment adherence and clinical progression in real-world settings, with ongoing follow-up to monitor patient outcomes and therapy compliance.

CONDITIONS

Brief Title

Molecular Inflammation Board at the Center for Personalized Medicine

Research Team

N

Nisar P Malek, Prof. Dr.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here